Hyung-Sik Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hyung-Sik Seo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Insoo Jang
Department of Internal Medicine, College of Korean Medicine, Woosuk University
4 shared publications Kang Kwon
Department of Ophthalmology, Otolaryngology and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea
4 shared publicationsDong-Jin Lee
Department of Ophthalmology, Otolaryngology and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea
3 shared publications- Eui-Hyoung Hwang
Department of Korean Medicine Rehabilitation, Pusan National University Korean Medicine Hospital, Yangsan, Republic of Korea
3 shared publications - Han-Sol Jeong
School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea
3 shared publications - Seung-Ug Hong
Department of Ophthalmology, Otolaryngology and Dermatology, College of Korean Medicine, Dongguk University, Goyang 10326, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 43 (2) , 105-123
Clinical Research Trends of Laser Therapy for Onychomycosis in Korea, China, and Japan, and Its Applicability in Korean Medicine: A Scoping Review
- 27 June 2026
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 43 (2) , 105-123
Open AccessClinical Research Trends of Laser Therapy for Onychomycosis in Korea, China, and Japan, and Its Applicability in Korean Medicine: A Scoping Review
- Open Access
- 27 December 2023
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 40 (4) , 141-148
Utilizing the Application of High-Intensity Yttrium Aluminum Garnet (YAG) Lasers Focused on Acupoint Irradiation
Maeum Lee, Yoomin Choi, Subin Ahn, Gihyang Lee, Eunhee Lee, Myungjin Yim, Hyung-Sik Seo, Eui-hyoung Hwang, Insoo Jang. Korean J Acupunct 2023;40:141-8. https://doi.org/10.14406/acu.2023.025
- 27 December 2023
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 40 (4) , 141-148
Open AccessUtilizing the Application of High-Intensity Yttrium Aluminum Garnet (YAG) Lasers Focused on Acupoint Irradiation
Maeum Lee, Yoomin Choi, Subin Ahn, Gihyang Lee, Eunhee Lee, Myungjin Yim, Hyung-Sik Seo, Eui-hyoung Hwang, Insoo Jang. Korean J Acupunct 2023;40:141-8. https://doi.org/10.14406/acu.2023.025
- Open Access
- 27 September 2023
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 40 (3) , 79-89
Clinical Application of Focused Ultrasound in Korean Medicine
Yoomin Choi, Maeum Lee, Nayeon Hur, Eunhee Lee, Hyugyong Choi, Hyung-Sik Seo, Eui-Hyoung Hwang, Insoo Jang. Korean J Acupunct 2023;40:79-89. https://doi.org/10.14406/acu.2023.009
- 27 September 2023
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 40 (3) , 79-89
Open AccessClinical Application of Focused Ultrasound in Korean Medicine
Yoomin Choi, Maeum Lee, Nayeon Hur, Eunhee Lee, Hyugyong Choi, Hyung-Sik Seo, Eui-Hyoung Hwang, Insoo Jang. Korean J Acupunct 2023;40:79-89. https://doi.org/10.14406/acu.2023.009
- Open Access
- 30 September 2020
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 23 (3) , 142-157
A Literature Analysis on Medicinal Use and Research of Cannabis in the Meiji Era of Japan
Byung-Soo Ahn, Seokhyun Kang, Kyung Hoon Lee, Seoyoon Kim, Jin Sung Park, Hyung-Sik Seo. J Pharmacopuncture 2020;23:142-57. https://doi.org/10.3831/KPI.2020.23.3.142
- 30 September 2020
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 23 (3) , 142-157
Open AccessA Literature Analysis on Medicinal Use and Research of Cannabis in the Meiji Era of Japan
Byung-Soo Ahn, Seokhyun Kang, Kyung Hoon Lee, Seoyoon Kim, Jin Sung Park, Hyung-Sik Seo. J Pharmacopuncture 2020;23:142-57. https://doi.org/10.3831/KPI.2020.23.3.142
- 1 August 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 45, 50-56
A multicenter study on the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitis
- 1 August 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 45, 50-56
A multicenter study on the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitis
- Open Access
- 27 March 2019
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 36 (1) , 36-43
The History of CO2 Laser Acupuncture and Moxibustion
Insoo Jang, Changsop Yang, Seungho Sun, Minjeong Jeong, Changho Han, Eui-Hyoung Hwang, Hyungsik Seo. Korean J Acupunct 2019;36:36-43. https://doi.org/10.14406/acu.2019.007
- 27 March 2019
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 36 (1) , 36-43
Open AccessThe History of CO2 Laser Acupuncture and Moxibustion
Insoo Jang, Changsop Yang, Seungho Sun, Minjeong Jeong, Changho Han, Eui-Hyoung Hwang, Hyungsik Seo. Korean J Acupunct 2019;36:36-43. https://doi.org/10.14406/acu.2019.007
- Open Access
- 1 January 2019
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 57 (1) , 105-111
Eclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
Context: Eclipta prostrata L. (Asteraceae) (EP) has been widely used for the treatment of skin disease in Asian traditional medicine. Objective: This study investigates the potency of EP in promoting hair growth in vivo and in vitro. Materials and methods: C57BL/6N mice were divided into four groups (n = 4) as follows: control (topical treatment of normal saline), topical 3% minoxidil to the dorsal skin of mice for 14 days, and low (1 mg/day) and high (10 mg/day) doses of EP orally administered once a day for 14 days. Dorsal hairs of C57BL/6N mice were depilated to synchronize anagen induction. Hair growth activity was evaluated by gross and microscopic observations. Sections of dorsal skin were stained with haematoxylin and eosin. We also treated the various concentrations of EP (5, 10 and 50 μg/mL) for 24 h on the human dermal papilla cells (HDPs) and examined the effects of EP on the expression of FGF-7 and mTOR signalling. Results: EP enhanced the induction of anagen in the dorsal skin of mice, characterized by the appearance of inner root sheath along with hair shaft, the emergence of hair shaft through the epidermis. EP increased the expression of FGF-7, while decreased the level of FGF-5 in C57/BL6 mice. EP also increased the expression of FGF-7, activated the mTOR signalling in HDPs. Discussion and conclusions: These results suggest that EP has a potency to enhance the growth of hair follicle, promoting hair growth through regulation of FGF-7 and FGF-5.
- 1 January 2019
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 57 (1) , 105-111
Open AccessEclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
Context: Eclipta prostrata L. (Asteraceae) (EP) has been widely used for the treatment of skin disease in Asian traditional medicine. Objective: This study investigates the potency of EP in promoting hair growth in vivo and in vitro. Materials and methods: C57BL/6N mice were divided into four groups (n = 4) as follows: control (topical treatment of normal saline), topical 3% minoxidil to the dorsal skin of mice for 14 days, and low (1 mg/day) and high (10 mg/day) doses of EP orally administered once a day for 14 days. Dorsal hairs of C57BL/6N mice were depilated to synchronize anagen induction. Hair growth activity was evaluated by gross and microscopic observations. Sections of dorsal skin were stained with haematoxylin and eosin. We also treated the various concentrations of EP (5, 10 and 50 μg/mL) for 24 h on the human dermal papilla cells (HDPs) and examined the effects of EP on the expression of FGF-7 and mTOR signalling. Results: EP enhanced the induction of anagen in the dorsal skin of mice, characterized by the appearance of inner root sheath along with hair shaft, the emergence of hair shaft through the epidermis. EP increased the expression of FGF-7, while decreased the level of FGF-5 in C57/BL6 mice. EP also increased the expression of FGF-7, activated the mTOR signalling in HDPs. Discussion and conclusions: These results suggest that EP has a potency to enhance the growth of hair follicle, promoting hair growth through regulation of FGF-7 and FGF-5.
- Open Access
- 1 March 2018
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 21 (1) , 14-17
A Case of Using Hominis Placenta and Soyeom Mixed Pharmacopuncture to Remove Melanocytic Nevus
Objective: It has been attempted to find out that Homine Placents and Soyeom mixed Pharmacopuncture (HSP) procedure is effective for the removal of melanocytic nevus of considerable size which cannot be applied to general acupuncture. Methods: Hominis placenta (0.5ml) and Soyeom (0.5ml) mixed pharmacopuncture (1.0ml) was subcutaneously injected in several places of melanocytic nevus. The treatment was performed about 20 times, once a week. Layer analysis of pigmentation was carried out using ECOSKIN. Results: One year after the HSP procedure, the pigmentation of the melanocytic nevus was slightly reduced and completely removed after 2 years of procedure. Conclusion: The HSP could be effective for removing hyperpigmentation in the melanocytic nevus.
- 1 March 2018
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 21 (1) , 14-17
Open AccessA Case of Using Hominis Placenta and Soyeom Mixed Pharmacopuncture to Remove Melanocytic Nevus
Objective: It has been attempted to find out that Homine Placents and Soyeom mixed Pharmacopuncture (HSP) procedure is effective for the removal of melanocytic nevus of considerable size which cannot be applied to general acupuncture. Methods: Hominis placenta (0.5ml) and Soyeom (0.5ml) mixed pharmacopuncture (1.0ml) was subcutaneously injected in several places of melanocytic nevus. The treatment was performed about 20 times, once a week. Layer analysis of pigmentation was carried out using ECOSKIN. Results: One year after the HSP procedure, the pigmentation of the melanocytic nevus was slightly reduced and completely removed after 2 years of procedure. Conclusion: The HSP could be effective for removing hyperpigmentation in the melanocytic nevus.
- Open Access
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 1062593
Can a Traditional Korean Manual Therapy Be a Complementary and Alternative Strategy for Cervicogenic Dizziness? A Study Protocol for a Randomized Controlled Trial
Cervicogenic dizziness is dizziness triggered by movement or positioning of the cervical spine and is often accompanied by neck pain or stiffness. This is a prospective, pragmatic, assessor‐blind, randomized controlled trial aimed at testing the efficacy and safety of adjuvant Chuna Manual Therapy (CMT) in patients with cervicogenic dizziness under usual care treatments. Fifty patients with cervicogenic dizziness will be randomly allocated to CMT or usual care (UC) groups in a 1 : 1 ratio. Extensive screening procedures, including examinations for central nervous system problems and nystagmus, will be applied to exclude other dizziness‐inducing disorders. The eligible participants will receive 12 sessions of CMT plus UC or only UC over 6 weeks. CMT includes mandatory and discretionary techniques, whereas UC includes electrotherapy, thermotherapy, and patient education. The efficacy will be evaluated primarily as Dizziness Handicap Inventory score. The severity and frequency of dizziness, the level of neck pain or stiffness, and the cervical range of motion will also be evaluated. Safety will be assessed by adverse events. The data will be statistically analyzed at p < 0.05. Trial Registration. This trial was registered with Clinical Research Information Service (CRIS) in Korea, KCT0002565, on 29 November 2017, https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=9610<ype=&rtype=.
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 1062593
Open AccessCan a Traditional Korean Manual Therapy Be a Complementary and Alternative Strategy for Cervicogenic Dizziness? A Study Protocol for a Randomized Controlled Trial
Cervicogenic dizziness is dizziness triggered by movement or positioning of the cervical spine and is often accompanied by neck pain or stiffness. This is a prospective, pragmatic, assessor‐blind, randomized controlled trial aimed at testing the efficacy and safety of adjuvant Chuna Manual Therapy (CMT) in patients with cervicogenic dizziness under usual care treatments. Fifty patients with cervicogenic dizziness will be randomly allocated to CMT or usual care (UC) groups in a 1 : 1 ratio. Extensive screening procedures, including examinations for central nervous system problems and nystagmus, will be applied to exclude other dizziness‐inducing disorders. The eligible participants will receive 12 sessions of CMT plus UC or only UC over 6 weeks. CMT includes mandatory and discretionary techniques, whereas UC includes electrotherapy, thermotherapy, and patient education. The efficacy will be evaluated primarily as Dizziness Handicap Inventory score. The severity and frequency of dizziness, the level of neck pain or stiffness, and the cervical range of motion will also be evaluated. Safety will be assessed by adverse events. The data will be statistically analyzed at p < 0.05. Trial Registration. This trial was registered with Clinical Research Information Service (CRIS) in Korea, KCT0002565, on 29 November 2017, https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=9610<ype=&rtype=.
- Open Access
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 4363716
A Herbal Medicine,Gongjindan, in Subjects with Chronic Dizziness (GOODNESS Study): Study Protocol for a Prospective, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group, Clinical Trial for Effectiveness, Safety, and Cost‐Effectiveness
This study protocol aims to explore the effectiveness, safety, and cost‐effectiveness of a herbal medication,Gongjindan(GJD), in patients with chronic dizziness. This will be a prospective, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, clinical trial. Seventy‐eight patients diagnosed with Meniere’s disease, psychogenic dizziness, or dizziness of unknown cause will be randomized and allocated to either a GJD or a placebo group in a 1 : 1 ratio. Participants will be orally given 3.75 g GJD or placebo in pill form once a day for 56 days. The primary outcome measure will be the Dizziness Handicap Inventory score. Secondary outcome measures will be as follows: severity (mean vertigo scale and visual analogue scale) and frequency of dizziness, balance function (Berg Balance Scale), fatigue (Fatigue Severity Scale) and deficiency pattern/syndrome (qi blood yin yang‐deficiency questionnaire) levels, and depression (Korean version of Beck’s Depression Inventory) and anxiety (State‐Trait Anxiety Inventory) levels. To assess safety, adverse events, including laboratory test results, will be monitored. Further, the incremental cost‐effectiveness ratio will be calculated based on quality‐adjusted life years (from the EuroQoL five dimensions’ questionnaire) and medical expenses. Data will be statistically analyzed at a significance level of 0.05 (two‐sided). This trial is registered with ClinicalTrials.govNCT03219515, in July 2017.
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 4363716
Open AccessA Herbal Medicine,Gongjindan, in Subjects with Chronic Dizziness (GOODNESS Study): Study Protocol for a Prospective, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group, Clinical Trial for Effectiveness, Safety, and Cost‐Effectiveness
This study protocol aims to explore the effectiveness, safety, and cost‐effectiveness of a herbal medication,Gongjindan(GJD), in patients with chronic dizziness. This will be a prospective, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, clinical trial. Seventy‐eight patients diagnosed with Meniere’s disease, psychogenic dizziness, or dizziness of unknown cause will be randomized and allocated to either a GJD or a placebo group in a 1 : 1 ratio. Participants will be orally given 3.75 g GJD or placebo in pill form once a day for 56 days. The primary outcome measure will be the Dizziness Handicap Inventory score. Secondary outcome measures will be as follows: severity (mean vertigo scale and visual analogue scale) and frequency of dizziness, balance function (Berg Balance Scale), fatigue (Fatigue Severity Scale) and deficiency pattern/syndrome (qi blood yin yang‐deficiency questionnaire) levels, and depression (Korean version of Beck’s Depression Inventory) and anxiety (State‐Trait Anxiety Inventory) levels. To assess safety, adverse events, including laboratory test results, will be monitored. Further, the incremental cost‐effectiveness ratio will be calculated based on quality‐adjusted life years (from the EuroQoL five dimensions’ questionnaire) and medical expenses. Data will be statistically analyzed at a significance level of 0.05 (two‐sided). This trial is registered with ClinicalTrials.govNCT03219515, in July 2017.